
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
A large pharmaceutical company in China will conduct a multisite clinical study using TrialMaster® EDC and Acuity Analytics, from OmniComm Systems, Inc. This company will utilize OmniComm's eClinical solutions in this multicenter, randomized, double-blind, placebo-controlled clinical trial of a treatment for a well-known cognitive disorder.
Read the full release






